Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:
“Immunotherapy works in elderly, but data gaps remain.
– Most cancer patients are ≥65, yet underrepresented in RCTs.
– Aging alters immunity, affecting ICI efficacy and irAEs.
– Inclusion matters. Real-world data needed.”
